Asthma Clinical Trials in DuBois, Pennsylvania

4 studies are recruiting for asthma in DuBois, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

    The aim of this study is to evaluate the efficacy of depemokimab administered as an adjunctive therapy, in participants with Type 2 asthma at risk of exacerbations compared to the guideline recommended standard of care (SoC).

    Stage
    Phase 3
    Ages
    12 and older
    Site
    GSK Investigational Site, DuBois, Pennsylvania
    Locations
    17 in total
    Run by
    GlaxoSmithKline
  2. Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

    This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Research Site, DuBois, Pennsylvania
    Locations
    221 in total
    Run by
    AstraZeneca
  3. Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

    Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and worsen unpredictably.\xa0The purpose of this study is to assess how depemokimab, a monoclonal antibody, affects the structure and function of the lungs in asthmat…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    GSK Investigational Site, DuBois, Pennsylvania
    Locations
    50 in total
    Run by
    GlaxoSmithKline
  4. A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

    The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life and functioning o…

    Stage
    Phase 2
    Ages
    18 to 70
    Site
    Clinical Research Associates of Central PA, LLC, DuBois, Pennsylvania
    Locations
    132 in total
    Run by
    Pfizer

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.